TrialNCT04314934Phase 2, phase 3Completed
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
Study sponsor: Anavex Life Sciences Corp. · AVXL
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2024-06-14Actual
Enrollment · participants300Actual
Source updated2024-08-12Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.